Transcatheter Arterial Chemoembolization (TACE) Market by Revenue and Number of Procedures, by Device Type (Micro Catheter and Micro Guidewire) Revenue and Volume; by Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) and Forecast 2017-2021

Transcatheter Arterial Chemoembolization (TACE) Market by Revenue and Number of Procedures, by Device Type (Micro Catheter and Micro Guidewire) Revenue and Volume; by Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) and Forecast 2017-2021

Transcatheter arterial chemoembolization or transarterial chemoembolization (TACE) is a minimally invasive procedure performed in interventional radiology to restrict a tumor’s blood supply. Small embolic particles coated with chemotherapeutic drugs are injected selectively through a catheter into an artery directly supplying the tumor. These particles both block the blood supply and induce cytotoxicity, attacking the tumor in several ways. Transarterial chemoembolization is also increasingly being used for patients on the transplant waiting list to prevent tumor growth.

The global transcatheter arterial chemoembolization (TACE) market provides market size (revenue US$ million) and number of procedures for TACE, market size (revenue US$ million) and volume (number of units) for micro catheter, micro guidewire used in TACE procedures, growth trends and forecast (CAGR%, 2017 to 2021). The global transcatheter arterial chemoembolization market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, South Korea, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World. The global transcatheter arterial chemoembolization market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis.

The TACE market has been estimated based on HCC prevalence and incidence in each country/region using the Barcelona Clinic Liver cancer (BCLC) staging system and treatment strategy and Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma, proposed by the Japan Society of Hepatology (JSH), 2012.

The global report tracks the major competitors operating in the market by market share analysis by key players, company overview, financial snapshot, key products, technologies and services offered. Major players operating in the global embolization in interventional oncology market and included in this report are Abbott Laboratories, Inc. (St. Jude Medical), ABK Biomedical, Inc., Asahi Intecc Co., Ltd., BioSphere Medical, Inc. (Merit Medical Systems, Inc.), Blockade Medical, (BALT International), Boston Scientific Corporation, Braile Biomedica, BTG International, Cook Medical, Inc., Covidien plc (Medtronic plc), Depuy Synthes (JnJ), Guerbet Group, Magle Life Science, Medtronic, Inc. (Covidien), Merit Medical Systems, Inc., Penumbra, Inc., Pfizer, Inc., PharmaCept, Piolax Medical Devices, Inc. (Piolax, Inc.), Sequent Medical (Terumo Corporation), Sirtex Medical Limited, Inc., Stryker Corporation, Surefire Medical, Inc., Terumo Medical Corporation, and Vascular Solutions, Inc..

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue US$ Million, 2014-2021)
    • Forecast Estimation (Revenue US$ Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Devices
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Device or Brand Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Transcatheter Arterial Chemoembolization (TACE) Market

1. Transcatheter Arterial Chemoembolization
1.1. Market size by Geography
1.2. Number of Procedures by Geography

2. Device Type
2.1. Micro Catheter
2.1.1. Market size by Geography
2.1.2. Number of Units Sold by Geography
2.2. Micro Guidewire
2.2.1. Market size by Geography
2.2.2. Number of Units Sold by Geography

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.3. Latin America (Brazil, Mexico, Rest of LA)
3.4. Asia Pacific (Japan, China, South Korea, Rest of APAC)
3.5. Middle East & Africa

4. Company Profiles
4.1. Abbott Laboratories, Inc., USA
4.2. ABK Biomedical, Inc., Canada
4.3. Asahi Intecc Co., Ltd., Japan
4.4. BioSphere Medical, Inc., USA (Merit Medical Systems, Inc.)
4.5. Blockade Medical, USA (BALT International)
4.6. Boston Scientific Corporation
4.7. Braile Biomedica, Brazil
4.8. BTG International
4.9. Cook Medical, Inc.
4.10. Covidien plc (Medtronic plc)
4.11. Depuy Synthes (JnJ)
4.12. Guerbet Group, France
4.13. Magle Life Science, Sweden
4.14. Medtronic, Inc. (Covidien), USA
4.15. Merit Medical Systems, Inc.
4.16. Penumbra, Inc., USA
4.17. Pfizer, Inc., USA
4.18. PharmaCept, Germany
4.19. Piolax Medical Devices, Inc. (Piolax, Inc.)
4.20. Sequent Medical (Terumo Corporation)
4.21. Sirtex Medical Limited, Australia
4.22. St. Jude Medical, Inc., USA
4.23. Stryker Corporation
4.24. Surefire Medical, Inc.
4.25. Terumo Medical Corporation
4.26. Vascular Solutions, Inc., USA

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*